Investing.com -- Mizuho initiated coverage of S&P Global with an "Outperform" rating and a price target of $599, while assigning Moody’s Corp a "Neutral" rating with a $504 target, citing valuation differences and growth potential in non-ratings businesses.Both companies’ credit rating agencies benefit from strong moats, pricing power, and high-margin business models that act as “to ...
By Jody Godoy(Reuters) -The U.S. Federal Trade Commission asked a federal court in Seattle on Wednesday to delay a September trial in its case alleging Amazon (NASDAQ:AMZN) misled consumers over its Prime subscription service, citing "severe resource shortfalls in terms of both money and personnel."Jonathan Cohen, an attorney for the FTC, told U.S. District Judge John Chun during a hearing that th ...
By David Lawder, Andrea Shalal and Jarrett RenshawWASHINGTON (Reuters) -Donald Trump threatened on Wednesday to escalate a global trade war with further tariffs on European Union goods, as major U.S. trading partners said they would retaliate for trade barriers already erected by the U.S. president.Just hours after Trump’s 25% duties on all U.S. steel and aluminum imports took effect, Trump said ...
Investing.com -- Mallinckrodt (OTC:MNKKQ) Pharmaceuticals and Endo Inc. are considering a potential merger that could be worth approximately $7 billion, according to Bloomberg, citing sources familiar with the matter. The two pharmaceutical companies, both of which have emerged from bankruptcies and faced lawsuits related to the US opioid crisis in recent years, are discussing a deal that would ...